Application of Poly-herbal Powder for Treating Acne Vulgaris
Launched by DR. MD. SHAHAB UDDIN · Jul 1, 2021
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
Background:
Due to increasing interest from acne patients concerned about the side effects associated with conventional therapies, complementary and alternative medicine (CAM) has been suggested as a new therapeutic modality for acne vulgaris. Herbal medicine is one of these CAM treatments. Different types of herbs powder has been using in patients with acne vulgaris in the traditional practice of Indian subcontinent as single form or compound. As for example, Azadirachta indica, Curcuma longa, Ocimum sanctum, Lens culinaris, Trigonella foenum-graecum and Mentha arvensis etc. These herbs h...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men and women both aged between 18-35 years
- • Presenting minimum 5 acne lesions (whiteheads, blackheads, papules, pustules, nodules)
- • Study subject who will be agreed with Online informed consent.
- Exclusion Criteria:
- • Have infected acne lesions
- • If study subject suffers from any serious medical conditions such as uncontrolled hypertension, diabetes mellitus, past or current malignancy, liver or kidney dysfunction, active pulmonary tuberculosis other severe dermatitis, or any infectious or systemic diseases.
- • Use of a topical medication containing steroids for the treatment of skin disease more than once per month.
- • Hypersensitive skin.
- • Erythema, or telangiectasia at the test site.
- • Use of the same or similar cosmetics (or pharmaceutical) on the test site within three months of screening.
- • Having undergone a skin peeling or having wrinkles removed within six months.
- • Any other reasons of unsuitability for the clinical trial at the discretion of the study.
About Dr. Md. Shahab Uddin
Dr. Md. Shahab Uddin is a distinguished clinical trial sponsor with extensive expertise in medical research and development. With a strong commitment to advancing healthcare, Dr. Uddin leads innovative clinical trials that focus on evaluating novel therapies and treatment modalities. His dedication to scientific rigor and patient safety is reflected in his collaborative approach, working closely with regulatory bodies and research institutions to ensure compliance and ethical standards. Dr. Uddin's contributions to the field are underscored by a robust portfolio of successful trials that aim to improve patient outcomes and enhance the overall quality of care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Munshiganj, , Bangladesh
Patients applied
Trial Officials
Dr.Md. S Uddin, BUMS
Principal Investigator
MPH student, Hamdard University Bangladesh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials